Global Intravenous Immunoglobulin Market is expected to reach USD 10.9 billion by 2022, according to a new study by Grand View Research, Inc.The increasing prevalence of immunodeficiency diseases coupled with the adoption of IVIG therapies is expected to fuel market growth over the forecast period. In addition, increasing off-label use of immunoglobulin and investments in the healthcare... Continue Reading →